Shareholders that lost money on Keros Therapeutics, Inc. (KROS) should contact Levi & Korsinsky about Securities Fraud Investigation - KROS
Keros Therapeutics(KROS) ACCESSWIRE Newsroom·2025-01-21 00:00文章核心观点 Keros Therapeutics公司股东若投资亏损可联系Levi & Korsinsky进行证券欺诈调查 [1] 分组1 - Keros Therapeutics公司股东投资亏损可联系Levi & Korsinsky进行证券欺诈调查 [1]